Citations

Clear

7552 citation(s) found for "Ku, Matthew".

Relapsing IgG4-related disease presenting with unilateral parotid mass and facial palsy
Ahmed, Nehaal , Kimbrough, Bradly, Koster, Matthew, Kimbrough, Bradly A. , Koster, Matthew J.

Mayo Clinic

Rheumatology | April 11, 2024 | Volume: 63 | Issue: 7 | Pages: e204-e205

10.1093/rheumatology/keae224 | PMID 38608192 Get It

What clinicians should know about surrogate end points in hematologic malignancies
Maurer, Matthew J. , Maurer, Matthew , Bommier, Côme , Lambert, Jérôme

Mayo Clinic

Blood | April 11, 2024 | Volume: 144 | Issue: 1 | Pages: 11-20

10.1182/blood.2023022269 | PMID 38603637 Get It

Abstract Use of surrogates as primary end points is commonplace in hematology/oncology clinical trials. As opposed to prognostic markers, surrogates are end points that can be measured early and yet can still capture the full effect of treatment, because it would be captured by the true outcome (eg, overall survival). We discuss the level of evidence of the most commonly used end points in hematology and share recommendations on how to apply and evaluate surrogate end points in research and clinical practice. Based on the statistical literature, this clinician-friendly review intends to build a bridge between clinicians and surrogacy specialists.
Establishing a 3-Tesla Magnetic Resonance Imaging Method for Assessing Diffuse Axonal Brain Injury in Rats
Frank, Dmitry , Gruenbaum, Benjamin F. , Zvenigorodsky, Vladislav , Shelef, Ilan , Matalon, Frederic , Tsafarov, Beatris, Frenkel, Amit , Boyko, Matthew , Frenkel, Amit , Boyko, Matthew , Gruenbaum, Benjamin Fredrick , Shelef, Ilan , Oleshko, Anna, Zlotnik, Alexander Anatolievich

Mayo Clinic

International Journal of Molecular Sciences | April 11, 2024 | Volume: 25 | Issue: 8 | Pages: 4234

10.3390/ijms25084234 | PMID 38673818 Get It

Traumatic brain injury (TBI) significantly contributes to death and disability worldwide. However, treatment options remain limited. Here, we focus on a specific pathology of TBI, diffuse axonal brain injury (DABI), which describes the process of the tearing of nerve fibers in the brain after blunt injury. Most protocols to study DABI do not incorporate a specific model for that type of pathology, limiting their ability to identify mechanisms and comorbidities of DABI. In this study, we developed a magnetic resonance imaging (MRI) protocol for DABI in a rat model using a 3-T clinical scanner. We compared the neuroimaging outcomes with histologic and neurologic assessments. In a sample size of 10 rats in the sham group and 10 rats in the DABI group, we established neurological severity scores before the intervention and at 48 h following DABI induction. After the neurological evaluation after DABI, all rats underwent MRI scans and were subsequently euthanized for histological evaluation. As expected, the neurological assessment showed a high sensitivity for DABI lesions indicated using the β-APP marker. Surprisingly, however, we found that the MRI method had greater sensitivity in assessing DABI lesions compared to histological methods. Out of the five MRI parameters with pathological changes in the DABI model, we found significant changes compared to sham rats in three parameters, and, as shown using comparative tests with other models, MRI was the most sensitive parameter, being even more sensitive than histology. We anticipate that this DABI protocol will have a significant impact on future TBI and DABI studies, advancing research on treatments specifically targeted towards improving patient quality of life and long-term outcomes.
Ten Years of Pathology on Twitter (X): Landscape and Evolution of Pathology on Twitter From 2012 to 2023
Tian, Roland, Wang, Eric , Sivasubramaniam, Priyadharshini , Baskota, Swikrity Upadhyay , Sharma, Anurag , Cecchini, Matthew J.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | April 10, 2024 | Volume: 149 | Issue: 1 | Pages: 75-82

10.5858/arpa.2023-0447-oa | PMID 38599590 Get It

Context.— Social media is a powerful tool in pathology education and professional networking that connects pathologists and pathology trainees from around the world. Twitter (X) appears to be the most popular social media platform pathologists use to share pathology-related content and connect with other pathologists. Although there has been some published research on pathology-related activity on Twitter during short time frames, to date there has not been published research examining pathology-related Twitter activity in totality from its earliest days of activity to recently. Objective.— To comprehensively evaluate the use of pathology on Twitter (X) during the last 10 years. Design.— Pathology-related tweets were systematically scraped from Twitter from January 2012 to January 2023 using pathology hashtags as a surrogate measure for all pathology content on Twitter. COVID-related tweets were approximated by tweets containing the term “COVID.” Results.— There were 591 812 unique pathology-related tweets identified during the time period, with #pathology being the most common hashtag used and #PathTwitter becoming more popular since 2020. There has been positive annual growth of pathology Twitter, with peaks in use during major pathology conferences. During the initial phases of the COVID-19 pandemic, a sustained increase in pathology tweets was observed. Conclusions.— Pathology Twitter has grown during the last 10 years and has become increasingly popular for pathology education and networking. With the changing landscape of social media platforms, this study provides an understanding of how pathology medical education and professional networking uses of social media happen and evolve over time.
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE
Fiske, Hannah W. , Shah, Samir A. , Al-Bawardy, Badr , Binion, David G. , Bohm, Matthew , Brand, Myron, Cohen, Benjamin L, Dueker, Jeffrey, Engels, Michael , Fine, Sean , Förster, E , Gaidos, Jill , Ginsburg, Philip, Goyal, Alka , Hanson, John S. , Herfath, Hans, Hull, Tracy L. , Kelly, Colleen , Lazarev, Mark , Levy, L. Campbell, Melia, Joanna , Philpott, Jessica, Qazi, Taha , Watson, Andrew , Wexner, Steven D. , Williams, Emmanuelle, Al‐Bawardy, Badr , Al-Bawardy, Badr , Bohm, Matthew , Fine, Sean , Forster, Erin , Gaidos, Jill K J , Hull, Tracy , Melia, Joanna , Qazi, Taha , Regueiro, Miguel , Wexner, Steven D , Ward, Chris , Holubar, Stefan D. , Barnes, Edward L. , Clarke, Kofi , Cohen, Benjamin L, Cross, Raymond K. , Farraye, Francis A. , Hanson, John, Philpott, Jessica R., Siegel, Corey A , Regueiro, Miguel

Mayo Clinic

Crohn's & Colitis 360 | April 10, 2024 | Volume: 6 | Issue: 2 | Pages: No page available

10.1093/crocol/otae022 | PMID 38720935 Get It

Abstract Background Since 2009, inflammatory bowel disease (IBD) specialists have utilized “IBD LIVE,” a weekly live video conference with a global audience, to discuss the multidisciplinary management of their most challenging cases. While most cases presented were confirmed IBD, a substantial number were diseases that mimic IBD. We have categorized all IBD LIVE cases and identified “IBD-mimics” with consequent clinical management implications. Methods Cases have been recorded/archived since May 2018; we reviewed all 371 cases from May 2018–February 2023. IBD-mimics were analyzed/categorized according to their diagnostic and therapeutic workup. Results Confirmed IBD cases made up 82.5% (306/371; 193 Crohn’s disease, 107 ulcerative colitis, and 6 IBD-unclassified). Sixty-five (17.5%) cases were found to be mimics, most commonly medication-induced (n = 8) or vasculitis (n = 7). The evaluations that ultimately resulted in correct diagnosis included additional endoscopic biopsies (n = 13, 21%), surgical exploration/pathology (n = 10, 16.5%), biopsies from outside the GI tract (n = 10, 16.5%), genetic/laboratory testing (n = 8, 13%), extensive review of patient history (n = 8, 13%), imaging (n = 5, 8%), balloon enteroscopy (n = 5, 8%), and capsule endoscopy (n = 2, 3%). Twenty-five patients (25/65, 38%) were treated with biologics for presumed IBD, 5 of whom subsequently experienced adverse events requiring discontinuation of the biologic. Many patients were prescribed steroids, azathioprine, mercaptopurine, or methotrexate, and 3 were trialed on tofacitinib. Conclusions The diverse presentation of IBD and IBD-mimics necessitates periodic consideration of the differential diagnosis, and reassessment of treatment in presumed IBD patients without appropriate clinical response. The substantial differences and often conflicting treatment approaches to IBD versus IBD-mimics directly impact the quality and cost of patient care.
Management of Intraosseous Subarcuate Loop of the Anterior Inferior Cerebellar Artery During Trigeminal Schwannoma Resection: 2-Dimensional Operative Video
Plou, Pedro , Leonel, Luciano, Donato, Glaudir , Carlson, Matthew L. , Peris‐Celda, Maria , De Bonis, Alessandro, Leonel, Luciano César P C, Bonis, Alessandro De

Mayo Clinic

Operative Neurosurgery | April 10, 2024 | Volume: 27 | Issue: 3 | Pages: 384-385

10.1227/ons.0000000000001126 | PMID 39145665 Get It

Conjugal Synucleinopathies: A Clinicopathologic Study
Adler, Charles H. , Halverson, Matthew , Shill, Holly A. , Driver‐Dunckley, Erika, Mehta, Shyamal H. , Caviness, John N., Belden, Christine M. , Long, Kathy E., Beach, Thomas G. , Driver-Dunckley, Erika, Beach, Thomas G , Adler, C H , Zhang, Nan , Driver‐Dunckley, Erika , Atri, Alireza , Serrano, Geidy E. , Shprecher, David , Sabbagh, Marwan Noel

Mayo Clinic

Movement Disorders | April 10, 2024 | Volume: 39 | Issue: 7 | Pages: 1212-1217

10.1002/mds.29783 | PMID 38597193 Get It

AbstractBackgroundWhile preclinical studies have shown that alpha‐synuclein can spread through cell‐to‐cell transmission whether it can be transmitted between humans is unknown.ObjectivesThe aim was to assess the presence of a synucleinopathy in autopsied conjugal couples.MethodsNeuropathological findings in conjugal couples were categorized as Parkinson's disease (PD), dementia with Lewy bodies (DLB), Alzheimer's disease with Lewy bodies (ADLB), incidental Lewy body disease (ILBD), or no Lewy bodies.ResultsNinety conjugal couples were included; the mean age of death was 88.3 years; 32 couples had no Lewy bodies; 42 couples had 1 spouse with a synucleinopathy: 10 PD, 3 DLB, 13 ADLB, and 16 ILBD; 16 couples had both spouses with a synucleinopathy: in 4 couples both spouses had PD, 1 couple had PD and DLB, 4 couples had PD and ADLB, 2 couples had PD and ILBD, 1 couple had DLB and ADLB, in 3 couples both had ADLB, and 1 couple had ADLB and ILBD. No couples had both spouses with ILBD.ConclusionsThis large series of 90 autopsied conjugal couples found 16 conjugal couples with synucleinopathies, suggesting transmission of synucleinopathy between spouses is unlikely. © 2024 International Parkinson and Movement Disorder Society.
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes
Lindborg, Stacy , Goyal, Namita , Katz, Jonathan, Burford, Matthew, Li, Jenny, Kaspi, Haggai , Abramov, Natalie, Boulanger, Bruno , Nicholson, Katharine, Mozaffar, Tahseen , Miller, Robert G. , Jenkins, Liberty, Baloh, Robert H. , Lewis, Richard A. , Staff, Nathan P. , Owegi, Margaret, Dagher, Bob, Blondheim-Shraga, N., Gothelf, Yaël, Levy, Yossef S., Kern, R. , Aricha, Revital , Windebank, Anthony J. , Bowser, Robert , Brown, Robert H. , Lindborg, Stacy R , Mozaffar, Tahseen , Lewis, Richard A , Staff, Nathan P , Blondheim-Shraga, Netta R , Bowser, Robert , Cudkowicz, Merit E , Berry, James D. , Cudkowicz, Merit

Mayo Clinic

Muscle & Nerve | April 9, 2024 | Volume: 69 | Issue: 6 | Pages: 719-729

10.1002/mus.28093 | PMID 38593477 Get It

Abstract Introduction/Aims Biomarkers have shown promise in amyotrophic lateral sclerosis (ALS) research, but the quest for reliable biomarkers remains active. This study evaluates the effect of debamestrocel on cerebrospinal fluid (CSF) biomarkers, an exploratory endpoint. Methods A total of 196 participants randomly received debamestrocel or placebo. Seven CSF samples were to be collected from all participants. Forty‐five biomarkers were analyzed in the overall study and by two subgroups characterized by the ALS Functional Rating Scale‐Revised (ALSFRS‐R). A prespecified model was employed to predict clinical outcomes leveraging biomarkers and disease characteristics. Causal inference was used to analyze relationships between neurofilament light chain (NfL) and ALSFRS‐R. Results We observed significant changes with debamestrocel in 64% of the biomarkers studied, spanning pathways implicated in ALS pathology (63% neuroinflammation, 50% neurodegeneration, and 89% neuroprotection). Biomarker changes with debamestrocel show biological activity in trial participants, including those with advanced ALS. CSF biomarkers were predictive of clinical outcomes in debamestrocel‐treated participants (baseline NfL, baseline latency‐associated peptide/transforming growth factor beta1 [LAP/TGFβ1], change galectin‐1, all p < .01), with baseline NfL and LAP/TGFβ1 remaining ( p < .05) when disease characteristics ( p < .005) were incorporated. Change from baseline to the last measurement showed debamestrocel‐driven reductions in NfL were associated with less decline in ALSFRS‐R. Debamestrocel significantly reduced NfL from baseline compared with placebo (11% vs. 1.6%, p = .037). Discussion Following debamestrocel treatment, many biomarkers showed increases (anti‐inflammatory/neuroprotective) or decreases (inflammatory/neurodegenerative) suggesting a possible treatment effect. Neuroinflammatory and neuroprotective biomarkers were predictive of clinical response, suggesting a potential multimodal mechanism of action. These results offer preliminary insights that need to be confirmed.
Adult-onset Leigh Syndrome: An analysis of the North American Mitochondrial Disease Consortium Database (P3-11.017)
Kroopnick, Adam, Houck, Alexander, Thakur, Kiran T. , Dugue, Rachelle , Goldstein, Amy , Gavrilova, Ralitza H. , Hove, Johan Van, Saneto, Russell P. , Buchsbaum, Richard , Thompson, John L.P. , Barca, Emanuele , Zolkipli‐Cunningham, Zarazuela , Falk, Marni J. , Demczko, Matthew M. , Larson, Austin , Hirano, Michio

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206383 Get It

The MAPT p.G324L and p.R406W Mutations Are Associated with Progressive Supranuclear Palsy with Unusual Involvement of the Medial Temporal Lobe (P2-3.002)
Ali, Farwa , Savica, Rodolfo , Stierwalt, Julie A. G., Pham, Nha Trang Thu, Rademakers, Rosa , Lowe, Val J. , Whitwell, Jennifer L. , Josephs, Keith A. , Badihian, Negin , Botha, Hugo , Machulda, Mary M. , Clark, Heather M. , Baker, Matthew , Whitwell, Jennifer L.

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206307 Get It